Testosterone therapy in men on active surveillance for prostate cancer is not associated with increased risk of disease progression
Andrew Vickers
@VickersBiostats
Biostatistician at Memorial Sloan Kettering Cancer Center. Special interest in prostate cancer, risk prediction, patient-reported outcomes, decision-making.
